HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

JIUYUAN GENE

5.100

+0.0100.20%

Volume:10.00K

Turnover:50.96K

Market Cap:1.22B

PE:7.75

High:5.105

Open:5.100

Low:5.100

Close:5.090

52wk High:15.424

52wk Low:4.600

Shares:240.00M

HK Float Shares:240.00M

Volume Ratio:0.20

T/O Rate:0.00%

Dividend:0.07

Dividend Rate:1.30%

EPS(LYR):0.658

ROE:8.50%

ROA:4.30%

PB:0.62

PE(LYR):7.75

PS:0.81

Loading ...

Overview Company News Filings

JIUYUAN GENE Receives Listing Approval for H-Share Full Circulation Reform

Hangzhou Jiuyuan Gene wins HKEX listing approval for 136,302,015 converted H shares

Jiuyuan Gene Updates on Public Float: Currently 22.22%, Full-Circulation Plan Targets 31.13% by Q2 2026

Bulletin Express

JIUYUAN GENE Announces Public Float at 22.22%, Aims to Restore Compliance by Q2 2026

Jiuyuan Genetic Biopharmaceutical Gets China Nod for Weight Management Drug Trial

MT Newswires Live

Hangzhou Jiuyuan Genetic Biopharmaceutical Co Ltd - Jy54 Injection Obtained Clinical Trial Approval in China

THOMSON REUTERS

BRIEF-Hangzhou Jiuyuan Genetic Biopharmaceutical Says JY54 Injection Obtains NMPA Approval To Conduct Clinical Trials In China

Hangzhou Jiuyuan Genetic Biopharmaceutical Co Ltd - Jy54 Injection Obtains Nmpa Approval to Conduct Clinical Trials in China

THOMSON REUTERS

Domestic Semaglutide's First Approval Faces Delays as Companies Cite Data Exclusivity Period Following Patent Expiry

Jiuyuan Gene Publishes 2025 Results, Declares RMB0.57 Dividend per 10 Shares and Seeks to Abolish Supervisory Committee

Bulletin Express

Jiuyuan Gene releases AGM agenda outlining 17 resolutions, including profit distribution plan and governance restructuring

Bulletin Express

Jiuyuan Gene Declares RMB0.57 Final Dividend per 10 Shares for FY2025; Payment Slated for 30 July 2026

Bulletin Express

JIUYUAN GENE to Distribute Final Dividend of RMB 0.57 per 10 Shares on July 30

Hangzhou Jiuyuan Gene Engineering proposes final dividend of RMB 0.57 per 10 shares

Jiuyuan Gene releases 2025 ESG report: 19.67 kt CO₂e emitted, 1,794-strong workforce and tighter 2026 resource-efficiency targets

Bulletin Express

Hangzhou Jiuyuan Gene Engineering publishes 2025 ESG report

九源基因2025年营收同比降4.59%至人民币13.063亿元，聚焦创新驱动与全球化战略

Bulletin Express

Jiuyuan Gene Updates Market on Public Float Restoration; Expects Compliance by Q2 2026

Bulletin Express

JIUYUAN GENE (02566) Completes Filing with CSRC for H-Share Full Circulation Plan

JIUYUAN GENE Receives CSRC Filing Notice for 136.30 Million-Share H Share Full Circulation

Bulletin Express

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/stock/02566/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"02566","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02566\",,,,,undefined,":{"symbol":"02566","market":"HK","secType":"STK","nameCN":"JIUYUAN GENE","latestPrice":5.1,"timestamp":1787299687019,"preClose":5.09,"halted":0,"volume":10000,"delay":0,"changeRate":0.001964636542239644,"floatShares":240000000,"shares":240000000,"eps":0.6581339028456271,"marketStatus":"Market Closed","change":0.01,"latestTime":"08-21 16:08:07","open":5.1,"high":5.105,"low":5.1,"amount":50964,"amplitude":0.000982,"askPrice":5.4,"askSize":2000,"bidPrice":5.1,"bidSize":12200,"shortable":0,"etf":0,"ttmEps":0.6681492985281778,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1787535000000},"marketStatusCode":7,"adr":0,"listingDate":1732723200000,"exchange":"SEHK","adjPreClose":5.09,"dividendRate":0.013007,"openAndCloseTimeList":[[1787275800000,1787284800000],[1787288400000,1787299200000]],"volumeRatio":0.19920318740972365,"lotSize":200,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02566\",,,,,undefined,":{"symbol":"02566","floatShares":240000000,"roa":"4.30%","roe":"8.50%","lyrEps":0.658134,"volumeRatio":0.19920318740972365,"shares":240000000,"dividePrice":0.066513,"high":5.105,"amplitude":0.000982,"preClose":5.09,"low":5.1,"week52Low":4.6,"pbRate":"0.62","psRate":"0.81","week52High":15.424,"institutionHeld":0,"latestPrice":5.1,"committee":0.71831,"eps":0.6581339028456271,"divideRate":0.013042,"volume":10000,"delay":0,"ttmEps":0.6681492985281778,"open":5.1,"prevYearClose":7.475,"prevWeekClose":5.41,"prevMonthClose":5.36,"prevQuarterClose":5.9,"fiveDayClose":5.41,"twentyDayClose":5.07,"sixtyDayClose":6.229,"dividendFrequency":"A","dividendGrowthYears":0,"fiveYearAvgDividendRate":0.008171466845277964},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/02566\",params:#limit:5,,,undefined,":[{"date":"2026-08-19","symbol":"02566","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1787103000000,"name":null,"time":"","dateTimestamp":1787068800000,"actualEps":null},{"date":"2026-06-17","symbol":"02566","amount":0.057,"announcedDate":"2026-03-30","type":"dividend","lastAmount":null,"market":"HK","newRecordDate":"2026-06-18","defaultRemindTime":1781659800000,"name":"九源基因","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-07-30","payableDate":"2026-06-18","currency":"CNY","dateTimestamp":1781625600000,"payDate":"2026-07-30"},{"date":"2026-03-30","symbol":"02566","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1774834200000,"name":null,"time":"","dateTimestamp":1774800000000,"actualEps":null},{"date":"2025-08-18","symbol":"02566","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1755480600000,"name":null,"time":"","dateTimestamp":1755446400000,"actualEps":null},{"date":"2025-06-13","symbol":"02566","amount":0.056,"announcedDate":"2025-03-26","type":"dividend","lastAmount":null,"market":"HK","newRecordDate":"2025-06-16","defaultRemindTime":1749778200000,"name":"九源基因","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-07-30","payableDate":"2025-06-16","currency":"CNY","dateTimestamp":1749744000000,"payDate":"2025-07-30"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"02566\",market:\"HK\",,,undefined,":[{"executeDate":"2025-06-13","recordDate":"2025-06-16","paymentDate":"2025-07-30","value":0.056,"currency":"CNY"},{"executeDate":"2026-06-17","recordDate":"2026-06-18","paymentDate":"2026-07-30","value":0.057,"currency":"CNY"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"02566\",market:\"HK\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/02566\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"02566","date":"2026-08-21","current":7.633025,"percent":0.002381,"low":7.557391,"twenty":10.071221,"median":12.803792,"eighty":16.5966,"high":28.852596,"avg":13.530617,"sd":4.356127,"marketCap":1231733640},"quantilePoints":[{"date":"2024-12-06","current":14.097915,"twenty":14.208262,"median":14.275695,"eighty":14.595644,"marketCap":1946012484},{"date":"2024-12-13","current":13.217326,"twenty":13.348436,"median":13.95821,"eighty":14.334483,"marketCap":1820859096},{"date":"2024-12-20","current":12.20261,"twenty":12.40882,"median":13.381214,"eighty":14.243818,"marketCap":1673619816},{"date":"2024-12-27","current":12.158366,"twenty":12.254449,"median":13.1954,"eighty":14.180675,"marketCap":1666257852},{"date":"2025-01-03","current":11.126814,"twenty":12.0799,"median":12.46117,"eighty":14.042033,"marketCap":1526380536},{"date":"2025-01-10","current":9.714633,"twenty":11.141125,"median":12.29741,"eighty":13.763077,"marketCap":1327607508},{"date":"2025-01-17","current":9.904165,"twenty":10.518129,"median":12.180488,"eighty":13.509332,"marketCap":1354601376},{"date":"2025-01-24","current":10.07429,"twenty":9.9409,"median":12.04207,"eighty":13.348436,"marketCap":1386503220},{"date":"2025-01-28","current":10.358786,"twenty":9.995541,"median":11.819979,"eighty":13.282881,"marketCap":1433128992},{"date":"2025-02-07","current":11.238302,"twenty":10.0243,"median":11.162591,"eighty":13.191014,"marketCap":1546012440},{"date":"2025-02-14","current":11.154484,"twenty":10.062805,"median":11.126814,"eighty":12.776093,"marketCap":1533742500},{"date":"2025-02-21","current":12.73316,"twenty":10.073062,"median":11.193598,"eighty":12.735779,"marketCap":1757055408},{"date":"2025-02-28","current":11.508443,"twenty":10.189099,"median":11.508443,"eighty":12.653552,"marketCap":1582822260},{"date":"2025-03-07","current":12.084413,"twenty":10.276651,"median":11.554796,"eighty":12.584056,"marketCap":1668711840},{"date":"2025-03-14","current":12.91496,"twenty":10.28916,"median":11.611229,"eighty":12.584056,"marketCap":1784049276},{"date":"2025-03-21","current":12.244709,"twenty":10.311241,"median":11.810026,"eighty":12.735779,"marketCap":1690797732},{"date":"2025-03-28","current":11.696332,"twenty":10.344738,"median":11.831112,"eighty":12.72799,"marketCap":1734969516},{"date":"2025-04-03","current":10.807781,"twenty":10.395616,"median":11.800074,"eighty":12.674918,"marketCap":1600000176},{"date":"2025-04-11","current":9.828764,"twenty":10.27298,"median":11.65378,"eighty":12.589531,"marketCap":1445398932},{"date":"2025-04-17","current":9.988361,"twenty":10.075173,"median":11.569961,"eighty":12.56072,"marketCap":1472392800},{"date":"2025-04-25","current":10.079541,"twenty":10.050182,"median":11.463659,"eighty":12.511173,"marketCap":1487116728},{"date":"2025-05-02","current":10.290636,"twenty":10.067013,"median":11.287756,"eighty":12.494061,"marketCap":1467484824},{"date":"2025-05-09","current":10.406872,"twenty":10.062805,"median":11.203375,"eighty":12.472285,"marketCap":1494478692},{"date":"2025-05-16","current":10.339488,"twenty":10.073062,"median":11.154484,"eighty":12.457737,"marketCap":1496932680},{"date":"2025-05-23","current":10.443848,"twenty":10.076938,"median":11.100884,"eighty":12.429027,"marketCap":1516564584},{"date":"2025-05-30","current":10.499086,"twenty":10.079206,"median":11.063697,"eighty":12.408842,"marketCap":1531288512},{"date":"2025-06-06","current":10.405237,"twenty":10.102813,"median":10.92653,"eighty":12.402573,"marketCap":1521472560},{"date":"2025-06-13","current":16.776007,"twenty":10.127345,"median":11.063697,"eighty":12.429027,"marketCap":2453988000},{"date":"2025-06-20","current":13.783342,"twenty":10.148232,"median":11.100884,"eighty":12.535947,"marketCap":2012270160},{"date":"2025-06-27","current":13.241991,"twenty":10.175286,"median":11.154484,"eighty":12.72799,"marketCap":1938650520},{"date":"2025-07-04","current":14.247042,"twenty":10.191457,"median":11.198369,"eighty":12.80722,"marketCap":2085889800},{"date":"2025-07-11","current":16.12378,"twenty":10.199228,"median":11.287756,"eighty":13.164345,"marketCap":2358282468},{"date":"2025-07-18","current":16.959198,"twenty":10.204599,"median":11.508443,"eighty":13.325525,"marketCap":2478527880},{"date":"2025-07-25","current":16.429296,"twenty":10.22327,"median":11.606189,"eighty":13.872228,"marketCap":2409816216},{"date":"2025-08-01","current":16.329429,"twenty":10.25109,"median":11.703755,"eighty":14.068336,"marketCap":2380368360},{"date":"2025-08-08","current":17.296232,"twenty":10.27298,"median":11.825546,"eighty":14.242565,"marketCap":2527607640},{"date":"2025-08-15","current":25.546022,"twenty":10.28665,"median":12.04207,"eighty":14.454008,"marketCap":3727607772},{"date":"2025-08-22","current":27.152477,"twenty":10.291424,"median":12.068084,"eighty":15.48419,"marketCap":3646626168},{"date":"2025-08-29","current":24.186548,"twenty":10.297713,"median":12.158366,"eighty":16.326447,"marketCap":3263804040},{"date":"2025-09-05","current":26.17651,"twenty":10.31224,"median":12.214209,"eighty":16.547432,"marketCap":3528834744},{"date":"2025-09-12","current":23.22216,"twenty":10.322989,"median":12.270192,"eighty":16.690567,"marketCap":3136196664},{"date":"2025-09-19","current":21.82033,"twenty":10.32445,"median":12.326094,"eighty":16.958366,"marketCap":2944785600},{"date":"2025-09-26","current":20.564467,"twenty":10.331172,"median":12.407292,"eighty":17.223519,"marketCap":2768098464},{"date":"2025-10-03","current":22.006879,"twenty":10.341379,"median":12.455816,"eighty":17.606421,"marketCap":2969325480},{"date":"2025-10-10","current":19.015463,"twenty":10.348945,"median":12.489783,"eighty":18.310381,"marketCap":2561963472},{"date":"2025-10-17","current":16.970486,"twenty":10.358786,"median":12.586793,"eighty":18.134776,"marketCap":2284662828},{"date":"2025-10-24","current":16.253675,"twenty":10.405237,"median":12.724544,"eighty":17.900127,"marketCap":2188957296},{"date":"2025-10-31","current":15.392522,"twenty":10.406545,"median":12.739707,"eighty":17.871014,"marketCap":2076073848},{"date":"2025-11-07","current":13.654382,"twenty":10.406872,"median":12.862233,"eighty":17.830642,"marketCap":1840491000},{"date":"2025-11-14","current":13.652109,"twenty":10.414705,"median":13.150654,"eighty":17.669327,"marketCap":1845398976},{"date":"2025-11-21","current":13.022772,"twenty":10.429703,"median":12.977364,"eighty":17.532486,"marketCap":1759509396},{"date":"2025-11-28","current":14.151953,"twenty":10.441671,"median":13.150654,"eighty":17.476552,"marketCap":1919018616},{"date":"2025-12-05","current":15.0671,"twenty":10.446315,"median":13.212896,"eighty":17.360095,"marketCap":2046625992},{"date":"2025-12-12","current":15.021249,"twenty":10.450076,"median":13.373682,"eighty":17.303573,"marketCap":2044172004},{"date":"2025-12-19","current":13.906512,"twenty":10.4562,"median":13.596735,"eighty":17.18567,"marketCap":1896932724},{"date":"2025-12-24","current":13.468772,"twenty":10.460694,"median":13.541362,"eighty":17.140598,"marketCap":1842944988},{"date":"2026-01-02","current":13.594612,"twenty":10.472165,"median":13.526709,"eighty":17.103787,"marketCap":1867484868},{"date":"2026-01-09","current":14.184539,"twenty":10.508332,"median":13.623361,"eighty":17.043007,"marketCap":1953374448},{"date":"2026-01-16","current":15.82386,"twenty":10.552044,"median":13.654647,"eighty":16.970089,"marketCap":2186209278},{"date":"2026-01-23","current":17.221546,"twenty":10.59039,"median":13.760784,"eighty":17.043007,"marketCap":2377029620},{"date":"2026-01-30","current":18.645413,"twenty":10.66635,"median":13.818506,"eighty":17.208843,"marketCap":2585326030},{"date":"2026-02-06","current":17.570145,"twenty":10.791312,"median":13.890789,"eighty":17.500019,"marketCap":2442411318},{"date":"2026-02-13","current":16.566637,"twenty":10.808038,"median":13.930604,"eighty":17.447639,"marketCap":2316142276},{"date":"2026-02-20","current":15.898541,"twenty":10.808553,"median":13.936612,"eighty":17.405456,"marketCap":2219535716},{"date":"2026-02-27","current":15.400942,"twenty":10.876548,"median":13.991046,"eighty":17.345071,"marketCap":2173647600},{"date":"2026-03-06","current":14.146009,"twenty":10.927529,"median":14.014987,"eighty":17.323365,"marketCap":1980434480},{"date":"2026-03-13","current":13.445786,"twenty":10.970802,"median":13.989227,"eighty":17.304533,"marketCap":1891073412},{"date":"2026-03-20","current":14.324288,"twenty":11.037013,"median":13.985049,"eighty":17.25142,"marketCap":2007001284},{"date":"2026-03-27","current":13.721414,"twenty":11.063706,"median":13.970301,"eighty":17.198531,"marketCap":1917640216},{"date":"2026-04-02","current":10.613398,"twenty":11.02367,"median":13.933608,"eighty":17.173124,"marketCap":1671293488},{"date":"2026-04-10","current":10.730025,"twenty":10.921534,"median":13.908042,"eighty":17.15803,"marketCap":1702690620},{"date":"2026-04-17","current":10.908083,"twenty":10.807781,"median":13.879703,"eighty":17.114449,"marketCap":1731672588},{"date":"2026-04-24","current":10.496724,"twenty":10.72787,"median":13.842971,"eighty":17.099223,"marketCap":1666463160},{"date":"2026-04-30","current":10.935086,"twenty":10.702023,"median":13.783342,"eighty":17.068754,"marketCap":1736502916},{"date":"2026-05-08","current":10.594139,"twenty":10.67921,"median":13.733566,"eighty":16.988616,"marketCap":1688199636},{"date":"2026-05-15","current":10.339602,"twenty":10.612541,"median":13.678484,"eighty":16.968896,"marketCap":1651972176},{"date":"2026-05-22","current":9.81785,"twenty":10.57772,"median":13.654515,"eighty":16.961058,"marketCap":1565026272},{"date":"2026-05-29","current":9.044003,"twenty":10.498141,"median":13.649387,"eighty":16.95795,"marketCap":1446683236},{"date":"2026-06-05","current":8.457984,"twenty":10.457266,"median":13.565546,"eighty":16.950392,"marketCap":1354907004},{"date":"2026-06-12","current":7.84515,"twenty":10.439494,"median":13.517899,"eighty":16.945188,"marketCap":1255885280},{"date":"2026-06-18","current":9.015379,"twenty":10.406872,"median":13.501167,"eighty":16.890943,"marketCap":1446683236},{"date":"2026-06-26","current":8.75713,"twenty":10.374116,"median":13.445786,"eighty":16.79658,"marketCap":1398379956},{"date":"2026-07-03","current":9.944532,"twenty":10.341471,"median":13.381214,"eighty":16.771208,"marketCap":1589177912},{"date":"2026-07-10","current":9.593587,"twenty":10.324058,"median":13.25487,"eighty":16.748323,"marketCap":1531213976},{"date":"2026-07-17","current":9.016752,"twenty":10.293006,"median":13.217326,"eighty":16.724074,"marketCap":1444268072},{"date":"2026-07-24","current":7.64292,"twenty":10.258532,"median":13.162063,"eighty":16.679208,"marketCap":1224488148},{"date":"2026-07-31","current":8.064769,"twenty":10.200205,"median":13.05573,"eighty":16.651478,"marketCap":1294527904},{"date":"2026-08-07","current":7.771324,"twenty":10.158149,"median":12.918657,"eighty":16.626081,"marketCap":1249847370},{"date":"2026-08-14","current":8.113953,"twenty":10.118328,"median":12.875119,"eighty":16.619851,"marketCap":1306603724},{"date":"2026-08-21","current":7.572239,"twenty":10.071221,"median":12.803792,"eighty":16.5966,"marketCap":1231733640}],"updateTime":1787451667536},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"02566\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1112628862","title":"JIUYUAN GENE Receives Listing Approval for H-Share Full Circulation Reform","url":"https://stock-news.laohu8.com/highlight/detail?id=1112628862","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1112628862?lang=en_us&edition=fundamental","pubTime":"2026-05-08 19:37","pubTimestamp":1778240247,"startTime":"0","endTime":"0","summary":"JIUYUAN GENE (02566) has announced that the company applied to the Stock Exchange's listing committee for approval to list and trade 136 million H-shares. These shares were converted from 136 million...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","IPOS","02566"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633458049","title":"Hangzhou Jiuyuan Gene wins HKEX listing approval for 136,302,015 converted H shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2633458049","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633458049?lang=en_us&edition=fundamental","pubTime":"2026-05-08 19:29","pubTimestamp":1778239788,"startTime":"0","endTime":"0","summary":"Hangzhou Jiuyuan Gene Engineering secured Hong Kong Stock Exchange listing clearance for 136,302,015 H shares to be created via conversion of an equal number of previously unlisted shares under its H-share full circulation plan.Converted shares represent about 56.44% of issued shares excluding treasury stock as of announcement date.Completion would leave all shares as H shares, with issued share capital comprising 245,398,800 H shares.Next steps include completing conversion and trading procedures for converted H shares, with progress updates to follow.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Hangzhou Jiuyuan Gene Engineering Co. Ltd. published the original content used to generate this news brief via IIS, the Issuer Information","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260508:nNDL86HBqV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02566"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1193270052","title":"Jiuyuan Gene Updates on Public Float: Currently 22.22%, Full-Circulation Plan Targets 31.13% by Q2 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=1193270052","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1193270052?lang=en_us&edition=fundamental","pubTime":"2026-05-06 16:44","pubTimestamp":1778057080,"startTime":"0","endTime":"0","summary":"Hangzhou Jiuyuan Genetic Biopharmaceutical Co., Ltd. (Jiuyuan Gene) reported that its public float remains at approximately 22.22%, below the minimum level required under Rule 19A.28B of the Hong...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02566"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1166172096","title":"JIUYUAN GENE Announces Public Float at 22.22%, Aims to Restore Compliance by Q2 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=1166172096","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1166172096?lang=en_us&edition=fundamental","pubTime":"2026-05-06 16:36","pubTimestamp":1778056615,"startTime":"0","endTime":"0","summary":"JIUYUAN GENE (02566) has issued an announcement stating that as of the date of this notice, the company's public float stands at approximately 22.22%. This percentage remains below the minimum...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02566","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630588219","title":"Jiuyuan Genetic Biopharmaceutical Gets China Nod for Weight Management Drug Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2630588219","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630588219?lang=en_us&edition=fundamental","pubTime":"2026-04-28 21:43","pubTimestamp":1777383784,"startTime":"0","endTime":"0","summary":"Hangzhou Jiuyuan Genetic Biopharmaceutical (HKG:2566) obtained clinical trial approval for the JY54 Injection from China's National Medical Products Administration, according to a Tuesday Hong Kong bourse filing.The product is intended to contribute to glycemic control and weight management.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["02566","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630305436","title":"Hangzhou Jiuyuan Genetic Biopharmaceutical Co Ltd - Jy54 Injection Obtained Clinical Trial Approval in China","url":"https://stock-news.laohu8.com/highlight/detail?id=2630305436","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630305436?lang=en_us&edition=fundamental","pubTime":"2026-04-28 19:20","pubTimestamp":1777375257,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260428:nFWN41B07O:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["02566","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630237042","title":"BRIEF-Hangzhou Jiuyuan Genetic Biopharmaceutical Says JY54 Injection Obtains NMPA Approval To Conduct Clinical Trials In China","url":"https://stock-news.laohu8.com/highlight/detail?id=2630237042","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630237042?lang=en_us&edition=fundamental","pubTime":"2026-04-28 18:28","pubTimestamp":1777372108,"startTime":"0","endTime":"0","summary":"BRIEF-Hangzhou Jiuyuan Genetic Biopharmaceutical Says JY54 Injection Obtains NMPA Approval To Conduct Clinical Trials In ChinaApril 28  - Hangzhou Jiuyuan Genetic Biopharmaceutical Co Ltd 2566.HK:JY54 INJECTION OBTAINS NMPA APPROVAL TO CONDUCT CLINICAL TRIALS IN CHINAFurther company coverage: 2566.HK ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260428:nFWN41B075:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02566","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630772703","title":"Hangzhou Jiuyuan Genetic Biopharmaceutical Co Ltd - Jy54 Injection Obtains Nmpa Approval to Conduct Clinical Trials in China","url":"https://stock-news.laohu8.com/highlight/detail?id=2630772703","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630772703?lang=en_us&edition=fundamental","pubTime":"2026-04-28 18:18","pubTimestamp":1777371485,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260428:nFWN41B075:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["02566","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1141827555","title":"Domestic Semaglutide's First Approval Faces Delays as Companies Cite Data Exclusivity Period Following Patent Expiry","url":"https://stock-news.laohu8.com/highlight/detail?id=1141827555","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1141827555?lang=en_us&edition=fundamental","pubTime":"2026-04-25 17:34","pubTimestamp":1777109647,"startTime":"0","endTime":"0","summary":"One month after the core compound patent for Novo Nordisk's (NVO.US) blockbuster weight-loss drug semaglutide expired, no domestic version of semaglutide has yet successfully gained approval. Several...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","BK4532","IE00BKVL7J92.USD","BK4599","LU0154236417.USD","NVOH","BK0239","BK0028","NVO","BK0187","BK0188","000513","LU1093756325.SGD","02566","BK4585","BK4588","LU1093756168.USD","LLY","NVOX","BK1161","01513","IE00BZ1G4Q59.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1132763389","title":"Jiuyuan Gene Publishes 2025 Results, Declares RMB0.57 Dividend per 10 Shares and Seeks to Abolish Supervisory Committee","url":"https://stock-news.laohu8.com/highlight/detail?id=1132763389","media":"Bulletin Express","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1132763389?lang=en_us&edition=fundamental","pubTime":"2026-04-24 20:46","pubTimestamp":1777034818,"startTime":"0","endTime":"0","summary":"Hangzhou Jiuyuan Genetic Biopharmaceutical Co., Ltd. (“Jiuyuan Gene”) has released its 2025 annual report and issued a 171-page AGM circular outlining key financial results, a planned cash dividend,...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02566"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1193748518","title":"Jiuyuan Gene releases AGM agenda outlining 17 resolutions, including profit distribution plan and governance restructuring","url":"https://stock-news.laohu8.com/highlight/detail?id=1193748518","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1193748518?lang=en_us&edition=fundamental","pubTime":"2026-04-24 20:42","pubTimestamp":1777034574,"startTime":"0","endTime":"0","summary":"Hangzhou Jiuyuan Genetic Biopharmaceutical Co., Ltd. (“Jiuyuan Gene”) has issued the proxy form for its Annual General Meeting scheduled for 14:00 on 15 June 2026 at Conference Room 3, No. 23 Eighth...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02566"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1123642963","title":"Jiuyuan Gene Declares RMB0.57 Final Dividend per 10 Shares for FY2025; Payment Slated for 30 July 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=1123642963","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1123642963?lang=en_us&edition=fundamental","pubTime":"2026-04-23 21:43","pubTimestamp":1776951823,"startTime":"0","endTime":"0","summary":"Hangzhou Jiuyuan Genetic Biopharmaceutical Co., Ltd. (Jiuyuan Gene) has announced a final ordinary cash dividend of RMB0.57 per 10 shares (approximately RMB0.057 per share) for the financial year...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02566"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1132935153","title":"JIUYUAN GENE to Distribute Final Dividend of RMB 0.57 per 10 Shares on July 30","url":"https://stock-news.laohu8.com/highlight/detail?id=1132935153","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1132935153?lang=en_us&edition=fundamental","pubTime":"2026-04-23 21:36","pubTimestamp":1776951414,"startTime":"0","endTime":"0","summary":"JIUYUAN GENE (02566) has announced that it will distribute a final dividend of RMB 0.57 for every 10 shares on July 30, 2026.","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","BK4588","BK4585","02566","VIG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629118837","title":"Hangzhou Jiuyuan Gene Engineering proposes final dividend of RMB 0.57 per 10 shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2629118837","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629118837?lang=en_us&edition=fundamental","pubTime":"2026-04-23 21:33","pubTimestamp":1776951187,"startTime":"0","endTime":"0","summary":"Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Hangzhou Jiuyuan Gene Engineering Co. Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange  , on April 23, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260423:nNDL8ZFKbV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02566"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1131767136","title":"Jiuyuan Gene releases 2025 ESG report: 19.67 kt CO₂e emitted, 1,794-strong workforce and tighter 2026 resource-efficiency targets","url":"https://stock-news.laohu8.com/highlight/detail?id=1131767136","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1131767136?lang=en_us&edition=fundamental","pubTime":"2026-04-23 19:23","pubTimestamp":1776943417,"startTime":"0","endTime":"0","summary":"Hangzhou-based biopharma company Jiuyuan Gene has published its second Environmental, Social and Governance (ESG) report, approved by the board on 30 March 2026. The document details governance...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02566"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629835821","title":"Hangzhou Jiuyuan Gene Engineering publishes 2025 ESG report","url":"https://stock-news.laohu8.com/highlight/detail?id=2629835821","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629835821?lang=en_us&edition=fundamental","pubTime":"2026-04-23 19:16","pubTimestamp":1776942983,"startTime":"0","endTime":"0","summary":"Hangzhou Jiuyuan Gene released its 2025 environmental, social, and governance report, outlining strategy to integrate sustainability into operations.Board of directors retained top-level oversight of ESG risk and target-setting, with a four-tier governance model spanning board, ESG committee, ESG office, ESG working group.Company set 2023 as base year for targets covering greenhouse gas emissions, waste management, energy use, water utilization.Report disclosed no litigation, investigations, or regulatory penalties tied to fraud, money laundering, corruption, or malpractice during reporting period.Jiuyuan ended year with 11 valid patents, 40 registered trademarks, 1 copyright as it stepped up intellectual property controls to support R&D pipeline.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should no","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260423:nNDL8WvZyq:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02566","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1171556606","title":"九源基因2025年营收同比降4.59%至人民币13.063亿元，聚焦创新驱动与全球化战略","url":"https://stock-news.laohu8.com/highlight/detail?id=1171556606","media":"Bulletin Express","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1171556606?lang=en_us&edition=fundamental","pubTime":"2026-04-23 17:15","pubTimestamp":1776935703,"startTime":"0","endTime":"0","summary":"九源基因（02566）公布2025年度业绩报告，全年实现营业收入人民币13.063亿元（2024年为人民币13.692亿元），同比下降4.59%。尽管营收有所下滑，企业依然保持了稳健的盈利能力，实现净利润人民币1.384亿元，与上年基本持平。公司全年毛利为人民币10.541亿元，毛利率由上年的79.00%提升至80.69%，主要得益于成本管控与生产效率的改善。...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"九源基因2025年营收同比降4.59%至人民币13.063亿元，聚焦创新驱动与全球化战略","news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02566"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1138236039","title":"Jiuyuan Gene Updates Market on Public Float Restoration; Expects Compliance by Q2 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=1138236039","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1138236039?lang=en_us&edition=fundamental","pubTime":"2026-04-08 17:23","pubTimestamp":1775640182,"startTime":"0","endTime":"0","summary":"Hangzhou Jiuyuan Genetic Biopharmaceutical Co., Ltd. (Jiuyuan Gene) released its latest monthly update, confirming that public float remains at 22.22%, below the minimum threshold stipulated under...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02566"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1176211726","title":"JIUYUAN GENE (02566) Completes Filing with CSRC for H-Share Full Circulation Plan","url":"https://stock-news.laohu8.com/highlight/detail?id=1176211726","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1176211726?lang=en_us&edition=fundamental","pubTime":"2026-04-02 21:30","pubTimestamp":1775136617,"startTime":"0","endTime":"0","summary":"JIUYUAN GENE (02566) announced that on April 2, 2026, the China Securities Regulatory Commission (CSRC) issued a filing notice to the company regarding its H-share full circulation plan. According to...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02566","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1158125386","title":"JIUYUAN GENE Receives CSRC Filing Notice for 136.30 Million-Share H Share Full Circulation","url":"https://stock-news.laohu8.com/highlight/detail?id=1158125386","media":"Bulletin Express","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1158125386?lang=en_us&edition=fundamental","pubTime":"2026-04-02 21:26","pubTimestamp":1775136361,"startTime":"0","endTime":"0","summary":"Hangzhou Jiuyuan Genetic Biopharmaceutical Co., Ltd. (JIUYUAN GENE) announced that the China Securities Regulatory Commission (CSRC) issued a filing notice on 2 April 2026 approving the company’s H...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02566"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":5,"pageCount":3,"totalSize":85,"code":"91000000","status":"200"}]}}